Cardiac sympathetic dysfunction in Parkinson's disease - Relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver

Clinical Neurology

Volumn 43, Issue 8, 2003, Pages 465-469

  Oka, Hisayoshi ^a   Yoshioka, Masayuki ^a   Morita, Masayo ^a   Mochio, Soichiro ^a   Inoue, Kiyoharu ^a  

^a NONE

Author keywords

123I MIBG scintigraphy; Baroreceptor function; Cardiac sympathetic dysfunction; Parkinson disease; Valsalva maneuver

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; EXPIRATORY FLOW RATE; HEART SCINTISCANNING; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; NON INVASIVE MEASUREMENT; PARKINSON DISEASE; PRESSORECEPTOR REFLEX; QT INTERVAL; RANDOMIZATION; RECEPTOR SENSITIVITY; RR INTERVAL; STATISTICAL SIGNIFICANCE; SYMPATHETIC FUNCTION; TONOMETRY; VALSALVA MANEUVER;

3-IODOBENZYLGUANIDINE; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; HEART; HUMANS; IODINE RADIOISOTOPES; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; VALSALVA MANEUVER;

EID: 0242493024     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yoshita M: Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998: 155: 60-67
2. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999: 67: 189-194
3. Oka H, Mochio S, Sato H, et al: Prolongation of QTc interval in patients with Parkinson's disease. Eur Neurol 1997: 37: 186-189
4. Wieland DM, Brown LE, Rogers WL, et al: Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 1981: 22: 22-31
5. Kline RC, Swanson DP, Wieland DM, et al: Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981: 22: 129-132
6. Tobes MC, Jaques S Jr, Wieland DM, et al: Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 1985: 26: 897-907
7. Sisson JC, Wieland DM, Sherman P, et al: Metaiodobenzyl guanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 1987: 28: 1620-1624
8. Sisson JC, Shapiro B, Meyers L, et al: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987: 28: 1625-1635
9. Sisson LC, Lynch JJ, Johnson J, et al: Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 1988: 116: 67-76
10. Oka H, Mochio S, Sato K, et al: Correlation of altered Q-T interval and sympathetic nervous system dysfunction in diabetic autonomic neuropathy. Eur Neurol 1994: 34: 23-29
11. Oka H, Mochio S, Sato K, et al: Prolongation of QTc interval and autonomic nervous dysfunction in diabetic patients. Diabetes Res Clin Pract 1996: 31: 63-70
12. Sandroni P, Benarroch EE, Low PA: Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol 1991: 71: 1563-1567
13. Orimo S, Ozawa E, Oka T, et al: Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 2001: 57: 1140-1141